comparemela.com

Latest Breaking News On - Matthewd galsky - Page 1 : comparemela.com

Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

United-states
Japan
South-korea
Taiwan
American
Pushkar-mutha
Mariat-bourlon
Tycel-jovelle-phillips
Tony-mok
Lin-wang
Peter-robert-galle
Charlene-mantia

Blood-based DNA test spares bladder cancer patients from unnecessary treatments

Testing for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following surgery, new research shows.

Paris
France-general
France
New-york
United-states
Thomas-powles
Matthew-galsky
Matthewd-galsky
Joost-boormans
Icahn-school-of-medicine-at-mount-sinai
Roche-ltd
European-association-of-urology

Trials Reveal Improved, Targeted Bladder Cancer Treatments

Trials Reveal Improved, Targeted Bladder Cancer Treatments
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Paris
France-general
France
Matthew-galsky
Thomas-powles
Joost-boormans
Matthewd-galsky
Roche-ltd
Barts-cancer-institute
European-association-of-urology-congress

Gemcitabine, Cisplatin, Nivolumab Facilitate Bladder Sparing

Clinical complete response of 43% seen for those with muscle-invasive bladder cancer receiving neoadjuvant gemcitabine, cisplatin, plus nivolumab

New-york
United-states
Matthewd-galsky
Icahn-school-of-medicine-at-mount-sinai
Healthday-news
Icahn-school
Mount-sinai
New-york-city

Gemcitabine, Cisplatin, and Nivolumab Facilitate Bladder Sparing in MIBC

Treatment with gemcitabine, cisplatin, and nivolumab facilitates bladder sparing in patients with muscle-invasive bladder cancer.

New-york
United-states
Matthewd-galsky
Icahn-school-of-medicine-at-mount-sinai
Healthday-news
Icahn-school
Mount-sinai

vimarsana © 2020. All Rights Reserved.